Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Vukojevic J, Milavi M, Perovi D, Ili S, ili AZ, Duran N, et al
HaCaT keratinocytes have also been proven to be good candidates for assessing skin irritancy and toxicity in conventional monolayer assays measuring using MTT reduction as the viability endpoint 21
KPV is positioned for individuals looking to reduce inflammation, improve gut health, support immunity or enhance recovery in a targeted and non hormonal way, a profile that complements the more regenerative role of BPC-157
Store reconstituted solutions at 2-8 C (short-term) or 20 C (long-term)
That said, TB-500 as sold for research is a fragment, and data specific to the fragment rather than the full protein remain limited and largely preclinical
This article is informational coverage of published research literature on a compound not currently stocked by Durham Peptides
